Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol for severe ovarian hyperstimulation syndrome
IRCT20180305038953N1Phase 3Completed
- Sponsor
- Sarem Fertility and Infertility Research Center
- Start
- Mar 2017
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label trial of Bronchitol in ovarian hyperstimulation syndrome (OHSS) (2 arms), sponsored by Sarem Fertility and Infertility Research Center. Primary endpoints: Abdominal girth, Weight and 5 more. Started Mar 2017; status: completed.
02
Drugs
Bronchitol
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on IRCT20180305038953N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180305038953N1.